Brinker Capital Investments, LLC Iovance Biotherapeutics, Inc. Transaction History

Brinker Capital Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2025	SELL	$7.78 - $14.19 $79,745 - $145,447	-10,250 Closed	0 $0
Q1 2024 Jul 31, 2025	BUY	$7.59 - $17.47 $77,797 - $179,067	10,250 New	10,250 $151,000
Q1 2021 May 12, 2021	SELL	$28.67 - $52.59 $310,152 - $568,918	-10,818 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $303,336 - $543,712	10,818 New	10,818 $502,000

291

219M

2.41M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $390M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.